Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preclinical data for FTY-720 presented at recent Japanese meetings

Oct. 22, 1999

Wyeth is first to cross the finish line with meningococcal group C conjugate vaccine

Oct. 22, 1999

Phase II clinical trials initiated for humanized anti-CD3 antibody developed at PDL

Oct. 21, 1999

North American Vaccine awarded contract to supply NeisVac-C in U.K.

Oct. 20, 1999

Chiron Behring, Abbott seek to terminate marketing agreements with North American Vaccines

Oct. 20, 1999

Antisense modulation of LFA-3 jointly investigated by Isis and Yale

Oct. 20, 1999

Trisulfide immunostimulants and their use in arteriosclerosis, etc.

Oct. 19, 1999

Progress toward a universal flu vaccine?

Oct. 18, 1999

RotaShield withdrawn from the market following reports of intussusception

Oct. 18, 1999

Wyeth-Ayerst reports U.S. launch of immunosuppressant

Oct. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...